Can Proton MR Spectroscopic and Perfusion Imaging Differentiate Between Neoplastic and Nonneoplastic Brain Lesions in Adults?
Authors:
- L.J. BrantLBL.J. Brant
- T. RizkTRT. Rizk
- J.D. WeingartJWJ.D. Weingart
- P.B. BarkerPBP.B. Barker
- A. HorskaAHA. Horska
Open Access
- 1 February 2008
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 29 (2) , 366-372
Abstract
BACKGROUND AND PURPOSE: Noninvasive diagnosis of brain lesions is important for the correct choice of treatment. Our aims were to investigate whether 1) proton MR spectroscopic imaging (1H-MRSI) can aid in differentiating between tumors and nonneoplastic brain lesions, and 2) perfusion MR imaging can improve the classification. MATERIALS AND METHODS: We retrospectively examined 69 adults with untreated primary brain lesions (brain tumors, n = 36; benign lesions, n = 10; stroke, n = 4; demyelination, n = 10; and stable lesions not confirmed on pathologic examination, n = 9). MR imaging and 1H-MRSI were performed at 1.5T before biopsy or treatment. Concentrations of N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) in the lesion were expressed as metabolite ratios and were normalized to the contralateral hemisphere. Dynamic susceptibility contrast-enhanced perfusion MR imaging was performed in a subset of patients (n = 32); relative cerebral blood volume (rCBV) was evaluated. Discriminant function analysis was used to identify variables that can predict inclusion in the neoplastic or nonneoplastic lesion groups. Receiver operator characteristic (ROC) analysis was used to compare the discriminatory capability of 1H-MRSI and perfusion MR imaging. RESULTS: The discriminant function analysis correctly classified 84.2% of original grouped cases (P < .0001), on the basis of NAA/Cho, Chonorm, NAAnorm, and NAA/Cr ratios. MRSI and perfusion MR imaging had similar discriminatory capabilities in differentiating tumors from nonneoplastic lesions. With cutoff points of NAA/Cho ≤0.61 and rCBV ≥1.50 (corresponding to diagnosis of the tumors), a sensitivity of 72.2% and specificity of 91.7% in differentiating tumors from nonneoplastic lesions were achieved. CONCLUSION: These results suggest a promising role for 1H-MRSI and perfusion MR imaging in the distinction between brain tumors and nonneoplastic lesions in adults.Keywords
This publication has 34 references indexed in Scilit:
- Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in childrenJournal of Magnetic Resonance Imaging, 2005
- Dynamic Magnetic Resonance Perfusion Imaging of Brain TumorsThe Oncologist, 2004
- Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2003
- Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation NecrosisNeurosurgery, 2002
- Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesionsNeuroradiology, 2002
- Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brainJournal of Magnetic Resonance Imaging, 2001
- In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imagingAnnals of Neurology, 1998
- Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopyNature Medicine, 1996
- Proton MR Spectroscopy of Intracranial TumoursJournal of Computer Assisted Tomography, 1990